Yang Wang

Safety analysis of acyclovir use in neonates based on the FDA Adverse Event Reporting System

Acyclovir is the first-line treatment for neonatal herpes simplex virus infection; however, safety evidence in neonates remains limited. This study aimed to evaluate the safety profile of acyclovir in neonates using real-world pharmacovigilance data from the Food and Drug Adminis...